CDC-RFA-GH-24-0058: Strengthening immunization program implementation in sub-national consequential geographies
Closed
This grant is closed. A newer notice from the same program is forecast: Capacity Building for National Immunization Programs in the Eastern Mediterranean Region (CDC-RFA-JG-27-0070). Status: Expected deadline February 12, 2027. It is in our archive of Centers for Disease Control - CGH notices from 2024.
Centers for Disease Control - CGH offered grants to any type of organization. It expected to make about 12 awards worth $225 million in total. Applications closed on March 4, 2024.
From the official notice on Grants.gov, last changed February 16, 2024. Checked November 7, 2026.
- Total funding$225 million
- Expected awards12
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | January 2, 2024 |
|---|---|
| Deadline | March 4, 2024 |
| Archived by Grants.gov | April 3, 2024 |
Who can apply
This opportunity was open to any type of organization.
All 15 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Ministries of Health (MOH) are eligible to apply and should follow instructions for Block 9 of the SF424. They must select option X: Other from the drop-down list in block 9. The MOH applicant will fill in the Other field. The applicant should describe their organization as a MOH.Public International Organizations (PIOs) are eligible to apply for this NOFO.All applications will be reviewed for responsiveness: Applicants are required to apply for work under at least one country component and may apply for multiple country components. For each country component, the applicant must submit separate project and budget narrative. The work plan should be included with the project narrative for each country component, as described in section D. Required Registrations, 11. Work Plan. The itemized country-specific budget narrative should be submitted as an attachment using the naming convention and guidance in section D. Required Registrations, 12. Budget Narrative. Applications not including country-specific project narratives with work plan, and country-specific budget narratives, will be non-responsive and not reviewed. Late submissions will be non-responsive and not be reviewed further. See section D. Required Registrations, part 4. Submission Dates and Times, for the application deadline. See section 15. d. Technical difficulties and 15. e. Paper Submission for additional information. Requests for paper application must be received 3 days prior to the application deadline. The applicant’s proposed budget for year one must not exceed the estimated annual funding of each component listed in section B. Award Information. If a funding amount exceeds the estimated amount of the country component, the application will be considered non-responsive and not reviewed. Applicants must prepare a single application including all countries for which they wish to apply. The application must specify the country on the title page of each project narrative. Applicants must specify the country(ies) in the project title in Block 15 of the SF424. Applicants must use the SF424 at link: http://apply07.grants.gov/apply/forms/sample/SF424_2_1-V2.1.pdf. Failure to indicate the country on the title page of the project narrative will result in non-responsive determination. Applicants must abide by the page number limitation in section D. Required Registrations, 10. Project Narrative. Any pages above the number of pages listed for the project narrative will not be reviewed. Appendices must have page numbers and be identified in the Table of Contents as appendices.
Is this a realistic fit?
- Most of the program's money (49% over five years) went to nonprofits.
- No cost sharing or match is required.
What the grant funds
The purpose of this NOFO is to increase immunization program capacity in high priority countries and targeted sub-national areas to identify underserved populations and develop tailored interventions to vaccinate underserved populations; implement comprehensive vaccine preventable disease (VPD) surveillance systems; improve preparedness and response to outbreaks of VPDs; and strengthen quality and sustainability of immunization delivery systems. This cooperative agreement will address targeted sub-national areas in the Democratic Republic of the Congo, Ethiopia, Nigeria, Brazil, Indonesia, and the Philippines. Applicants may apply to work in one or more countries and must indicate the country/countries in their application. Work conducted under this NOFO will be critical to achieve VPD control, elimination, and eradication targets (i.e., polio eradication, measles and rubella elimination, hepatitis B elimination, maternal and neonatal tetanus elimination) and more broadly reduce VPD-related morbidity and mortality.
Who has won Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security grants before
From fiscal 2021 to 2025, Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security (93.318) awarded $1.3 billion across 306 grant awards, an average of $4.3 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| African Field Epidemiology Network LTD | 6 | $147 million | |
| The Task Force for Global Health, Inc. | Georgia | 7 | $138 million |
| World Health Organization, Somalia | 14 | $125 million | |
| Association of Public Health Laboratories, Inc. (the) | Maryland | 3 | $61.5 million |
| The Johns Hopkins University | Maryland | 5 | $42.7 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, CDC-RFA-JG-27-0070, which is forecast.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is CDC-RFA-GH-24-0058 still open?
No. It closed on March 4, 2024. A newer notice is forecast: CDC-RFA-JG-27-0070, expected deadline February 12, 2027.
Who can apply for Strengthening immunization program implementation in sub-national consequential geographies?
Centers for Disease Control - CGH accepted applications from any type of organization. The notice adds further conditions, so read its eligibility section.
What is the deadline for Strengthening immunization program implementation in sub-national consequential geographies?
Closed March 4, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
About $225 million in total across about 12 awards.
Who has won Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security grants before?
The largest recipients over five fiscal years were African Field Epidemiology Network LTD, The Task Force for Global Health, Inc., World Health Organization, Somalia. The program made 306 awards worth $1.3 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)